The 2024 revisions to the McDonald criteria increase the proportion of people who can be diagnosed with MS and allow for ...
The 41st ECTRIMS Congress kicks off in Barcelona, Spain, with a focus on advances in understanding and diagnosing MS.
The U.S. Food and Drug Administration is delaying by three months its decision on whether or not to approve tolebrutinib for ...
A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...
An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...
An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...
Columnist Ben Hofmeister worries about his MS cognitive symptoms worsening and wonders if he'll even be aware of the changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback